Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
PloS One (2014) 9:e94433
Results announced in December 2025 confirmed the Phase 2 findings at a longer timepoint (Lilly Press Release, Dec 2025): The 28.7% weight loss at 68 weeks exceeds both semaglutide (~15% in STEP trials) and tirzepatide (~22.5% in SURMOUNT trials) at similar timepoints
They then slowly scale up in dosage over the course of several months
The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon
Men on GLP-1s May Lose More Belly Fat Than Women Do In general, men tend to have more visceral fat (a particularly harmful type of fat surrounding the abdominal organs) compared with subcutaneous fat (under the skin), says Holt
PMID 19748060
US$ 20.86
US$ 21.26
US$ 27.52
US$ 26.26
US$ 25.16
US$ 27.84
